⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—PGIM India Small Cap Fund - Growth - Direct PlanDirect · Growth
₹18.81 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFPGIM India Small Cap Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Small cap FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹18.81 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★★
BenchmarkNifty Smallcap 250 - TRIBSE Health Care - TRI
Fund ManagerUtsav MehtaNikhil Mathur
Inception29 Jul 202104 Oct 2023
Returns
1Y6.01%22.64%
3Y15.00%30.41%
5Y11.68%—
Since Inception13.05%29.15%
Risk
16.6814.07
0.790.59
0.591.59
2.9721.67
1.143.48
-12.68%-9.23%
Costs
Expense Ratio0.94%1.03%
Exit Load0.50% on or before 90D, Nil after 90D1% on or before 30D, Nil after 30D
Min SIP₹1,000₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
PGIM India Sm…96%
HDFC MF96%
4.1%

Only 4.1% of holdings by weight are common between PGIM India Small Cap Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Common holdingPGIM India Small Cap Fund - Growth - Direct PlanHDFC MF
Krishna Institute of Medical Sciences Ltd2.91%2.10%
Torrent Pharmaceuticals Ltd.2.00%3.65%

Category context: Equity vs Equity. Open the full Screener →